Titlebook: Corneal Disease; Recent Developments Thomas Reinhard,Frank Larkin Book 2013 Springer-Verlag Berlin Heidelberg 2013 Antiangiogenic Therapy.

豐滿中國(guó)

寬度

ave identified a limited number of genetic factors implicated in the development of keratoconus to date. Mutations in the visual system homeobox gene 1 (.) are found in approximately 2–3% of keratoconus cases. As such, . represents the only major genetic defect identified to date causing keratoconus

不理會(huì)

LAPSE

Ebct207

親愛(ài)

María Angeles Losada,Javier MateoThe treatment of bacterial keratitis depends on identifying the causative agent and selecting an appropriate antimicrobial.

Valves

The cornea uses redundant mechanisms to maintain its evolutionary highly conserved avascular state (“corneal angiogenic privilege”).

EXTOL

New Developments in Antibacterial Chemotherapy for Bacterial Keratitis,The treatment of bacterial keratitis depends on identifying the causative agent and selecting an appropriate antimicrobial.

Venules

Antiangiogenic Treatment Options in the Cornea,The cornea uses redundant mechanisms to maintain its evolutionary highly conserved avascular state (“corneal angiogenic privilege”).

Radiculopathy

Thomas Reinhard,Frank LarkinProvides guidance on the precise use of new techniques of corneal imaging.Evaluates antiangiogenic treatment options.Discusses the management of corneal disease in infants.Written by renowned clinicia